Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

This year. We're going Beyond.

S&P/ASX 200 morning report – CBA, FLT and FMG shares in focus

The Australian share market and S&P/ASX 200 (ASX: XJO) is expected to rise at the open on Thursday. Here’s what you need to know.

The rotation continues

The rotation rally continued on Wednesday as investors adjusted portfolios to what appears to be a sooner-than-expected return to normal. Every sector finished higher, with COVID beneficiaries including Consumer Discretionary (+0.7%) and healthcare (0.2%) among the ‘weakest’.

The winner once again was the energy sector (+5.0%), with the oil price adding another 4% on Wednesday after jumping 9% earlier in the week. One of the biggest beneficiaries has been Woodside Petroleum Ltd (ASX: WPL) which finished 6.3% higher, despite facing issues with the sale of its Scarborough asset.

Markets are clearly pricing in a quick return to normal trade and travel, but the potential supply responses from key oil producers remain the biggest unknown. Interestingly, despite the rally the share price remains at levels not seen since 2005. It was a busy day on the environmental front, with Woolworths Ltd (ASX: WOW), announcing its intention to be carbon neutral by 2050, and Fortescue Metals Group (ASX: FMG) founder Andrew “Twiggy” Forrest outlining a plan to become the largest renewable energy producer in the world.

CBA profit collapses 16%, Flight Centre (ASX:FLT) raises $400 million & bonds sink

Commonwealth Bank of Australia (ASX: CBA) was the latest bank to offer a quarterly update, confirming a 16% fall in cash profit to $1.8 billion. The result bodes well for dividends in 2021, with management confirming that deferred loans had fallen 60% from their peak, down to just 52,000 mortgages from a peak of 210,000.

With conditions returning to normal in Australia, CBA has pushed forward with an aggressive lending strategy, approving $5.6 billion in new loans during the quarter, twice the sector average. The strength of CBA’s franchise remains in the full display, with another $15.8 billion in low-cost customer deposits received and now supporting 74% of the group’s loan book.

The key pressure facing the CBA and the other banks is a shrinking net interest margin (NIM) or the profit they make on every dollar they lend. Interestingly, the spike in Government Bond yields overnight, which are resulting in capital losses in traditional bond strategies, is actually a positive for the banking sector.

PayPal stock bounces back

US markets reverted to type, with the technology-driven Nasdaq leading the way overnight after an incredible few days for beaten down ‘value’ stocks. Among the leaders were Zoom Communications (NASDAQ: ZM) and PayPal Inc. (NASDAQ: PYPL), which finished 9.9% and 4.9% higher, respectively.

Analysts have suggested the initial ‘vaccine rally’ was likely driven by the winding down of short positions in companies ranging from travel to theme parks rather than outright growth in demand for these companies.

Fears are growing about another round of lockdown measures in the US as daily new cases remain above 100,000, with the potential for significant economic damage despite the growing likelihood of a vaccine in early 2021. Evidencing the delicate balancing act between recovery and support, the European Central Bank indicated it would be continuing with its planned increase in bond purchases in December, wary of removing support too early.

My focus this week has been seeking to understand how significant the economic damage has been thus far, the risk that stimulus has been withdrawn too early, and the inflation implications, if any, of the recent spike in bond yields.

Got $1,000? Try our #1 growth stock...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Got $1,000? Try this...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, Drew does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: